Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rationale for targeting the Wnt signalling modulator Dickkopf‐1 for oncology
Michael H. Kagey, Xi He
British Journal of Pharmacology (2017) Vol. 174, Iss. 24, pp. 4637-4650
Open Access | Times Cited: 117

Showing 26-50 of 117 citing articles:

Wnt signalling pathways in chronic lymphocytic leukaemia and B‐cell lymphomas
Pavlína Janovská, Vı́tězslav Bryja
British Journal of Pharmacology (2017) Vol. 174, Iss. 24, pp. 4701-4715
Open Access | Times Cited: 55
Dual-platform affinity proteomics identifies links between the recurrence of ovarian carcinoma and proteins released into the tumor microenvironment
Florian Finkernagel, Silke Reinartz, Maximiliane Schuldner, et al.
Theranostics (2019) Vol. 9, Iss. 22, pp. 6601-6617
Open Access | Times Cited: 49
Manipulating the Wnt/β-catenin signaling pathway to promote anti-tumor immune infiltration into the TME to sensitize ovarian cancer to ICB therapy
Jaclyn Wall, Selene Meza‐Perez, Carly Bess Scalise, et al.
Gynecologic Oncology (2020) Vol. 160, Iss. 1, pp. 285-294
Open Access | Times Cited: 43
Safety, Efficacy, and Biomarker Results from a Phase Ib Study of the Anti-DKK1 Antibody DKN-01 in Combination with Pembrolizumab in Advanced Esophagogastric Cancers
Samuel J. Klempner, Johanna C. Bendell, Victoria Villaflor, et al.
Molecular Cancer Therapeutics (2021) Vol. 20, Iss. 11, pp. 2240-2249
Open Access | Times Cited: 40
Carboxylesterase Notum Is a Druggable Target to Modulate Wnt Signaling
Elliott D. Bayle, Fredrik Svensson, Benjamin N. Atkinson, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 8, pp. 4289-4311
Open Access | Times Cited: 38
Proteomic Profiling and Artificial Intelligence for Hepatocellular Carcinoma Translational Medicine
Nurbubu T. Moldogazieva, Innokenty M. Mokhosoev, S. P. Zavadskiy, et al.
Biomedicines (2021) Vol. 9, Iss. 2, pp. 159-159
Open Access | Times Cited: 37
DKK1 is a predictive biomarker for response to DKN-01: Results of a phase 2 basket study in women with recurrent endometrial carcinoma
Rebecca C. Arend, Jhalak Dholakia, C. de Castro, et al.
Gynecologic Oncology (2023) Vol. 172, pp. 82-91
Closed Access | Times Cited: 16
Circulating tumor cells as “liquid biopsies” to understand cancer metastasis
Dennis Woo, Min Yu
Translational research (2018) Vol. 201, pp. 128-135
Open Access | Times Cited: 44
An update of Wnt signalling in endometrial cancer and its potential as a therapeutic target
A. Coopes, Claire Henry, Estelle Llamosas, et al.
Endocrine Related Cancer (2018) Vol. 25, Iss. 12, pp. R647-R662
Open Access | Times Cited: 41
Immunological history governs human stem cell memory CD4 heterogeneity via the Wnt signaling pathway
Hassen Kared, Shu Wen Tan, Mai Chan Lau, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 34
The Dickkopf1 and FOXM1 positive feedback loop promotes tumor growth in pancreatic and esophageal cancers
Hirokazu Kimura, Ryota Sada, Naoki Takada, et al.
Oncogene (2021) Vol. 40, Iss. 26, pp. 4486-4502
Open Access | Times Cited: 32
LRPs in WNT Signalling
Gary Davidson
Handbook of experimental pharmacology (2021), pp. 45-73
Closed Access | Times Cited: 28
Targeting ligand-dependent wnt pathway dysregulation in gastrointestinal cancers through porcupine inhibition
Dustin J. Flanagan, Simon A. Woodcock, Caroline Phillips, et al.
Pharmacology & Therapeutics (2022) Vol. 238, pp. 108179-108179
Open Access | Times Cited: 22
DKK1‐CKAP4 signal axis promotes hepatocellular carcinoma aggressiveness
Kosuke Iguchi, Ryota Sada, Shinji Matsumoto, et al.
Cancer Science (2023) Vol. 114, Iss. 5, pp. 2063-2077
Open Access | Times Cited: 13
The Multifaceted Role of WNT Signaling in Alzheimer’s Disease Onset and Age-Related Progression
William W. Kostes, David A. Brafman
Cells (2023) Vol. 12, Iss. 8, pp. 1204-1204
Open Access | Times Cited: 13
DKN-01 in Combination With Tislelizumab and Chemotherapy as First-Line Therapy in Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: DisTinGuish
Samuel J. Klempner, Mohamad Bassam Sonbol, Zev A. Wainberg, et al.
Journal of Clinical Oncology (2024)
Closed Access | Times Cited: 4
Dickkopf-1 (Dkk1) protein expression in breast cancer with special reference to bone metastases
Mariz Kasoha, Rainer M. Bohle, Anita Seibold, et al.
Clinical & Experimental Metastasis (2018) Vol. 35, Iss. 8, pp. 763-775
Closed Access | Times Cited: 36
Identification of DKK-1 as a novel mediator of statin effects in human endothelial cells
Marta Pontremoli, Maura Brioschi, Roberta Baetta, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 36
Perspectives on the role of Wnt biology in cancer
Christopher K. Mirabelli, Roel Nusse, David A. Tuveson, et al.
Science Signaling (2019) Vol. 12, Iss. 589
Closed Access | Times Cited: 30
DKK1 drives immune suppressive phenotypes in intrahepatic cholangiocarcinoma and can be targeted with anti‐DKK1 therapeutic DKN‐01
Edward J. Jarman, Marta Horcas‐Lopez, Scott H. Waddell, et al.
Liver International (2022) Vol. 43, Iss. 1, pp. 208-220
Open Access | Times Cited: 18
Potentially actionable molecular alterations in particular related to poor oncologic outcomes in salivary gland carcinomas
Julia Pikul, Marcin M. Machnicki, Anna Rzepakowska, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Stroma-derived Dickkopf-1 contributes to the suppression of NK cell cytotoxicity in breast cancer
Seunghyun Lee, Biancamaria Ricci, Jennifer Tran, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Modulation of Wnt/Beta-Catenin Pathway by Major Dietary Phytochemicals Against Breast Cancer Development
Noah Lieb, Amina Tran, Martha Torres, et al.
Biology (2025) Vol. 14, Iss. 2, pp. 194-194
Open Access
Dickkopf-1 promotes tumor progression of gefitinib- resistant non-small cell lung cancer through cancer cell-fibroblast interactions
Munkyung Choi, Yong June Choi, Young Ju Lee, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
A multi-faceted discovery strategy identifies functional antibodies binding to cysteine-rich domain 1 of hDKK1 for cancer immunotherapy via Wnt non-canonical pathway
Linya Wang, Sean M. Peterson, Marisa Yang, et al.
Oncogene (2025)
Open Access

Scroll to top